Drug Delivery Products: United States
This report forecasts US drug delivery product demand in US dollars at the manufacturers' level to 2019. Total demand is segmented by type in terms of: oral, parenteral, and other types. Total demand is also segmented by application as follows: central nervous system agents, hormones and related agents, respiratory agents, ant-infective agents, cardiovascular agents, gastrointestinal agents, and other applications.
To illustrate historical trends, total demand is provided in an annual series from 2004 to 2014; the various segments are reported at five-year intervals for 2009 and 2014. A Market Environment section provides pertinent background on historical trends, key economic indicators, trade, and pharmaceutical regulations. A Segmentation and Forecasts section defines product types and applications, discusses market drivers and constraints, identifies substitute products when applicable, and assesses the impact of key drivers and constraints on each product type and application segment over the forecast period.
Further analysis includes an Industry Structure section, which surveys the supply base and profiles the leading firms competing to serve the US market. A one-page, introductory Highlights section summarizes key findings from this 30-page report, and a Resources section lists contributing sources as well as resources available for further research.
Back to Top